In most of the world, disease burden is shifting toward non-communicable diseases and injuries and is less driven by infectious illnesses. Many countries have seen significant declines in HIV/AIDS, but success has varied across regions and countries. Although the epidemic peaked in magnitude in 2005, HIV/AIDS is still among the top 10 causes of death globally, and nearly 30 million people are living with HIV worldwide.
Over the past 20 years, HIV has become a manageable chronic illness for people who can be tested and treated. Interventions such as antiretroviral therapies (ART), prophylaxis, and prevention of mother-to-child transmission have been successful. The burden of HIV/AIDS has increased in Southern sub-Saharan Africa, however, where access to medical care may be limited.
Billions of dollars are spent every year to fight HIV/AIDS in developing countries. Funding increased after 2000 when the Millennium Development Goals (MDGs) were established, aiming to stop the spread of HIV by 2015. Our MDG data visualization depicts trends in HIV/AIDS incidence, prevalence, and mortality, by country, between 1990 and 2013.
IHME tracks mortality and disease burden from HIV/AIDS through the Global Burden of Disease (GBD) study, and funding for interventions in the developing world through our Financing Global Health work. The Access, Bottlenecks, Costs, and Equity+ (ABCE+) project evaluates ART and HIV-prevention programs in parts of Africa and India.